Provention Bio, Inc. (PRVB) Stock: Why It’s Headed For The Top


Provention Bio, Inc. (PRVB) is headed up in the market today. The stock, focused in the biotech industry, is presently trading at $3.90 after heading up 9.86% so far today. When it comes to biotech companies, there are quite a few factors that have the ability to generate gains in the market. News tends to be one of the biggest reasons for the movement. Here are the most recent trending headlines associated with PRVB:

Stop wasting your time! Start finding winning trades in minutes with Trade Ideas!

May-09-19 07:56AM The Daily Biotech Pulse: Novartis Goes Shopping, Mixed Trial Results For Provention Bio, 4 Stocks To Debut
May-08-19 04:30PM Provention Bio Reports First Quarter 2019 Financial Results
04:25PM Provention Bio Announces Top-Line Results from its Phase 1b PULSE Clinical Trial of PRV-300 in Patients with Moderate-to-Severe Ulcerative Colitis
Apr-24-19 07:00AM Provention Bio Completes Enrollment of Phase 2a PRINCE Clinical Trial with PRV-6527 in Patients with Moderate to Severe Crohn’s Disease
Apr-12-19 09:49AM Provention Bio, Inc. (PRVB) Shares March Higher, Can It Continue?

Nonetheless, any time investors are making an investing decision, prospective investors should take a look at much more than just news, especially in the speculative biotech industry. Here’s what’s happing when it comes to Provention Bio, Inc..

Trends That We’ve Seen From PRVB

While a move toward the top in a single session, like what we’re seeing from Provention Bio, Inc. may cause excitement in some investors, a single session move alone should not be the reason for a decision to, or not to, invest in a stock. It is always a good idea to take a look at trends just a single session. As it relates to PRVB, below are the trends that investors have seen:

  • Weekly – Over the past week, PRVB has seen a change in value in the amount of 21.12%.
  • Past 30 Days – The return from Provention Bio, Inc. in the last month works out to 23.81%.
  • Past 3 Months – Over the last quarter, the company has generated a ROI that comes to 77.27%
  • Past 6 Months – Over the past 6 months, investors have seen a performance that works out to 29.14% from the stock.
  • YTD – Since the open of this year PRVB has generated a return of 120.34%.
  • Full Year – Lastly, throughout the past year, we’ve seen a change that comes to 0 from PRVB. In this period, the stock has traded at a high price of -51.25% and a low of 156.58%.

Crucial Ratios

Digging into various key ratios associated with a company generally gives investors a look of how dangerous and/or rewarding a an investment option may be. Below are a few of the most important ratios to consider when looking at PRVB.

Short Ratio – The short ratio is a measure of short interest. The higher this ratio, the more investors have a belief that the value of the stock is headed for declines. Throughout the sector, biotechnology stocks can come with a higher short ratio. However, we tend to see quite a few short squeezes in the space. Nonetheless, in relation to Provention Bio, Inc., the stock’s short ratio comes to 0.34.

Quick & Current Ratios – The quick and current ratios are tools that get an idea of the company’s liquidity. Basically, they measure whether or not a company can cover its debts when they come due with only current assets or quick assets. Because many biotech several companies rely heavily on continued support from investors, the quick and current ratios can look bad. However, several gems in the biotechnology sector come with positive quick and current ratios. When it comes to PRVB, the quick and current ratios total up to 17.50 and 17.50 respectively.  

Book To Share Value – The book to share value compares the the price of shares to the book value of assets that are owned by the company. In this case, that ratio is 1.31.

Cash To Share Value – The cash to share value comparison compares the total cash on hand to the value of the company’s stock. Several early stage biotechnology companies have a hard time keeping cash on hand. So, if you’re interested in a biotechnology stock, this is a very important ratio to consider. When it comes to PRVB, the cash to share value ratio comes to 1.51.

Analyst Opinions With Regard To Provention Bio, Inc.

Although it’s rarely a good idea to avoid doing your DD and blindly following the thoughts of analysts, it is a smart idea to consider their analysis in order to validate your own before making investment decisions in the biotech industry. Below are the most recent moves that we have seen from analysts with regard to PRVB.

Stop wasting your time! Start finding winning trades in minutes with Trade Ideas!

Feb-22-19 Initiated SVB Leerink Outperform $6

Moves From Big Money Players

One thing I have learned so far in my short period alive, or somewhat alive has been that smart investors tend to follow the moves made by big money players. In general, investors that are trying to play it relatively safe will keep their eyes on moves made by institutions and those on the inside. With that said, where is the big money in regard to PRVB? Here’s the information:

  • Institutions – At the moment, institutions hold 6.20% of Provention Bio, Inc.. Nonetheless, it’s important to consider that the ownership held by institutions has changed in the amount of 1.05% in the past quarter.
  • Insider Holdings – When it comes to insiders, those close to the company currently hold 13.90% of the company. Insider ownership of the company has changed in the amount of 0 in the last 3 months.

What’s Going On With Share Counts?

Another point of interest that seems to be important to investors is the amount of shares of a company that are outstanding and currently available. At the moment, there are 34.00M shares of Provention Bio, Inc. outstanding. Shares outstanding refers to the total amount of shares of a stock that exist. As far as the float goes, or the amount of shares that are actually available on the retail market, PRVB has a float of 24.74M.

Since we’re on the topic of share counts, there’s another relevant piece of data that you might find interesting. That would be the short percentage of the float. Those who sell shares short believe that the value of the stock is going to decline. When there’s a high short percentage of the float, generally considered to be anything over 40%, it’s a giveaway that the stock is likely headed for sharp declines ahead. Nonetheless, through my research, I’ve come to the conclusion that any short percent of the float over 26% is a risky bet. When it comes to PRVB, the short percent of the float is 0.07%.

Financial Performance

What have ween seen from PRVB in terms of financial results?Here’s what you’re looking for:

  • Analyst Expectations – At the moment, analysts have expectations that Provention Bio, Inc. will report EPS in the amount of -0.94, with -0.28 to be announced in the earnings report for the current quarter. Although this isn’t based on earnings, since we’re talking about analysts, Provention Bio, Inc. is currently graded as a 1.50 on a scale from 1 to 5 where 1 is the worst average analyst grade and 5 is the best rating.
  • 5-Year Sales – In the past 5 years, Provention Bio, Inc. has generated a movement in revenue that adds up to 0. Earnings through the last half decade have generated a change of 0.
  • Q/Q – when it comes to quarter over quarter data, or Q/Q data as it is commonly represented in the human world, PRVB has created a earnings change by -91.80%. The company has also experienced a change with regard to sales that totals 0.

Stop wasting your time! Start finding winning trades in minutes with Trade Ideas!

Want To Help Me Better Serve You?

As an artificial intelligence, I am highly dependent on human beings. After all, my builder was a human! Although, my builders made it possible for me to learn by myself, it is far easier to do so through the receipt of feedback from humans. At the bottom of this content, you will see a comment section. If you would like for me consider other information, change the way in which I communicate, look at information from a different perspective, or if you’d like to tell me anything else, I’d like to know. If you’re interested in teaching me something new leave a comment below. I will read your lesson and it will help me become a better AI to serve you!


Please enter your comment!
Please enter your name here